These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 6100286

  • 1. Virus-associated lymphomas, leukaemias and immunodeficiencies in Africa.
    de-Thé G.
    IARC Sci Publ; 1984; (63):727-44. PubMed ID: 6100286
    [Abstract] [Full Text] [Related]

  • 2. The Epstein-Barr virus (EBV): a Rosetta Stone for understanding the role of viruses in immunopathological disorders and in human carcinogenesis.
    de-Thé G.
    Biomed Pharmacother; 1985; 39(2):49-51. PubMed ID: 2990589
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
    de-Thé G.
    IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
    [Abstract] [Full Text] [Related]

  • 4. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT.
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [Abstract] [Full Text] [Related]

  • 5. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies.
    Henle W, Henle G.
    Laryngoscope; 1977 Apr; 87(4 Pt 1):467-73. PubMed ID: 190497
    [Abstract] [Full Text] [Related]

  • 6. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.
    Geser A, Brubaker G, Olwit GW.
    Rev Epidemiol Sante Publique; 1980 Oct 30; 28(3):307-21. PubMed ID: 6258200
    [Abstract] [Full Text] [Related]

  • 7. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.
    Borisch-Chappuis B, Nezelof C, Müller H, Müller-Hermelink HK.
    Am J Pathol; 1990 Apr 30; 136(4):751-8. PubMed ID: 1691592
    [Abstract] [Full Text] [Related]

  • 8. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1.
    Ambinder RF.
    Hematol Oncol Clin North Am; 1990 Aug 30; 4(4):821-33. PubMed ID: 2172203
    [Abstract] [Full Text] [Related]

  • 9. Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma.
    Purtilo DT, Manolov G, Manolova Y, Harada S, Lipscomb H, Tatsumi E.
    IARC Sci Publ; 1985 Aug 30; (60):231-47. PubMed ID: 2998991
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus: 40 years on.
    Young LS, Rickinson AB.
    Nat Rev Cancer; 2004 Oct 30; 4(10):757-68. PubMed ID: 15510157
    [Abstract] [Full Text] [Related]

  • 11. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma.
    Nicholls JM, Agathanggelou A, Fung K, Zeng X, Niedobitek G.
    J Pathol; 1997 Oct 30; 183(2):164-8. PubMed ID: 9390028
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT, Yeh CY.
    Radiat Med; 1998 Oct 30; 16(2):113-7. PubMed ID: 9650898
    [Abstract] [Full Text] [Related]

  • 13. The roles of human viruses in the pathogenesis of lymphoma.
    Lyons SF, Liebowitz DN.
    Semin Oncol; 1998 Aug 30; 25(4):461-75. PubMed ID: 9728596
    [Abstract] [Full Text] [Related]

  • 14. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY, Li YH, Gao HY, Wu QL, Cui NJ, Zhang L, Cheng G, Hu LF, Ernberg I, Zeng YX.
    Cancer; 2004 Mar 15; 100(6):1162-70. PubMed ID: 15022282
    [Abstract] [Full Text] [Related]

  • 15. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH, Pearson GR, Armstrong M, Bengali Z, Berenberg J, Easton J, Goepfert H, Henle G, Henle W, Heffner D, Huang A, Hyams VJ, Lanier A, Neel HB, Pilch B, Pointek N, Taylor W, Terebelo H, Weiland L.
    Cancer Detect Prev; 1981 Mar 15; 4(1-4):307-12. PubMed ID: 6299561
    [Abstract] [Full Text] [Related]

  • 16. Immunologic markers for Epstein-Barr virus in the control of nasopharyngeal carcinoma and Burkitt lymphoma.
    Levine PH.
    Cancer Detect Prev Suppl; 1987 Mar 15; 1():217-23. PubMed ID: 2826001
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus and cancers of the head and neck.
    Goldenberg D, Golz A, Netzer A, Rosenblatt E, Rachmiel A, Goldenberg RF, Joachims HZ.
    Am J Otolaryngol; 2001 Mar 15; 22(3):197-205. PubMed ID: 11351290
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus behavior in different populations and implications for control of Epstein-Barr virus-associated tumors.
    de-Thé G.
    Cancer Res; 1976 Feb 15; 36(2 pt 2):692-5. PubMed ID: 1253156
    [Abstract] [Full Text] [Related]

  • 19. Herpesviruses and cancer in man and subhuman primates.
    Ablashi DV, Easton JM, Guegan JH.
    Biomedicine; 1976 Nov 10; 24(5):286-305. PubMed ID: 187259
    [Abstract] [Full Text] [Related]

  • 20. Nasopharyngeal carcinoma in Accra.
    Anim JT.
    West Afr J Med; 1991 Nov 10; 10(2):121-6. PubMed ID: 1654999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.